Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M16.7Revenue (TTM) $M12.5Net Margin (%)106Altman Z-Score63.7
Enterprise Value $M5.4EPS (TTM) $0.3Operating Margin %46.5Piotroski F-Score5
P/E(ttm)1.3Beneish M-Score--Pre-tax Margin (%)46.5Higher ROA y-yN
Price/Book0.810-y EBITDA Growth Rate %--Quick Ratio76.7Cash flow > EarningsN
Price/Sales1.35-y EBITDA Growth Rate %--Current Ratio76.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-74.2ROA % (ttm)52.4Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)70.8Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M43.9ROIC % (ttm)4,253Gross Margin Increase y-yN

Gurus Latest Trades with ENZN

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

ENZN is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ENZN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LEBUHN ROBERTDirector 2013-09-19Sell55,926$1.72-77.91view
LEBUHN ROBERTDirector 2012-08-14Sell5,820$6.58-94.22view
LEBUHN ROBERTDirector 2012-08-10Sell1,933$6.58-94.22view
HEBARD GEORGEInterim PEO and Interim COO 2012-06-20Buy5,000$6.88-94.48view
Rackear Andrew D.VP and General Counsel 2012-06-05Sell1,614$6.81-94.42view
Conover CharlesSVP, R&D Program Management 2012-06-05Sell25,000$6.78-94.4view
Young Richard ADirector 2012-03-15Sell2,000$6.92-94.51view
Rackear Andrew D.VP and General Counsel 2011-11-10Sell3,766$6.68-94.31view
Buchbinder AbyVP, Clinical Development 2011-11-08Sell2,700$7.06-94.62view
LEBUHN ROBERTDirector 2011-06-01Sell8,702$10.57-96.4view

Quarterly/Annual Reports about ENZN:

News about ENZN:

Articles On GuruFocus.com
Top Micro-Cap Picks From the Gurus Jun 23 2015 
Baupost’s Seth Klarman Takes 10% Stake in Keryx Biopharmaceuticals May 12 2014 
GuruFocus Real Time Picks of the Week Jan 10 2014 
Seth Klarman Buys New Stock Kindred Biosciences, Cut Stake in Enzon Jan 10 2014 
Billionaires Hold Bargains, 40% Off or More Sep 11 2013 
Charles Brandes Top Second Quarter Portfolio Changes Aug 09 2013 
First Pacific Advisors’ Top New Buys Aug 08 2012 
Enzon Inc. Reports Operating Results (10-K) Mar 16 2011 
Carl Icahn Buys NAV, CHK, ENZN, AMLN, CMC, Feb 15 2011 
Despite Bearish View, Seth Klarman Holds These Stocks: VSAT, THRX, NWSA, BBEP, ENZN, CSE Nov 25 2010 

More From Other Websites
ENZON PHARMACEUTICALS, INC. Financials Aug 23 2016
Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 Aug 12 2016
OTC Markets Group Welcomes Enzon Pharmaceuticals, Inc. to OTCQX Aug 10 2016
ENZON PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report Aug 10 2016
ENZON PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events Aug 09 2016
OTC Markets Group Welcomes Enzon Pharmaceuticals, Inc. to OTCQX Aug 09 2016
ENZON PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders,... Jul 05 2016
Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q1, 2016 By the Numbers : May 26, 2016 May 26 2016
ENZON PHARMACEUTICALS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a... May 16 2016
ENZON PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report May 09 2016
Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: 2015 By the Numbers Mar 24 2016
ENZON PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other... Mar 21 2016
ENZON PHARMACEUTICALS INC Files SEC form 8-K, Other Events Feb 23 2016
ENZON PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other... Feb 09 2016
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of... Jan 27 2016
Enzon Pharmaceuticals, Inc. Earnings Analysis: Q3, 2015 By the Numbers Dec 10 2015
ENZON PHARMACEUTICALS INC Files SEC form 8-K, Other Events Dec 07 2015
ENZON PHARMACEUTICALS INC Files SEC form 8-K, Other Events Dec 03 2015
What Do Hedge Funds Think of Enzon Pharmaceuticals, Inc. (ENZN)? Nov 25 2015
ENZON PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Nov 12 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)